Clinical Trials · NCT03010683
Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- University of Athens
- Enrollment
- 60
- Start date
- Nov 2015
- Locations
- 1 site, Greece
- Primary endpoint
- Differences in Pulse Wave Velocity at Baseline and 3, 6 and 12 Months After Treatment With Metformin or Agonist GLP-1R.